First New York Securities’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

First New York Securities’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-206,109	Closed	-$15.5M	–	357
2015 Q3	$15.5M	Buy	206,109 +198,209	+2,509%	+$14.8M	6.96%	2
2015 Q2	$595K	Buy	+7,900	New	+$423K	0.3%	45
2014 Q3	–	Sell	-500	Closed	-$19.2K	–	654
2014 Q2	$19.2K	Buy	+500	New	+$17.5K	0.02%	103

First New York Securities's KYTH Position: Q4 2015 in Review

First New York Securities sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 206,109 shares — an estimated $15.5M sold.

First New York Securities first reported a position in KYTH in Q2 2014 and held it in 3 quarters. The position peaked at $15.5M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

First New York Securities reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
First New York Securities sold 206,109 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $15.5M.
First New York Securities first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2014 and held it in 3 quarters.
First New York Securities's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $15.5M in Q3 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on First New York Securities's 13F filing for Q4 2015, filed 25 Jan 2016.